Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor signaling pathway
Immunology Letters Aug 22, 2017
Wu JL, et al. – Therapeutic efficacy of sodium butyrate and its mechanism in the liver and upper small intestine were examined in S100/Freund's complete adjuvant induced autoimmune hepatitis. Via maintaining the integrity of small intestine and inhibiting the inflammatory response, sodium butyrate demonstrated the potential to prevent liver injury in S100/FreundÂs complete adjuvant induced autoimmune hepatitis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries